Insilico Medicine grabs $37 mln

Hong Kong-based Insilico Medicine, an artificial intelligence company, has secured $37 million in funding. Qiming Venture Partners led the round with participation from other investors that included Eight Roads, F-Prime Capital, Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Pavilion Capital and BOLD Capital Partners.

North AmericaUSBriefs